A

AbCellera

474 employees

AbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes.

Investor insights

Sectors invested in

biotechnology and veterinary medicine2
Veterinary2
Biotechnology2
Biopharma2

Funding rounds participated in

$13M sweet spot round size

Most of their 2 investments are in rounds between $10M and $15M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Protein engineering
Cell Enrichment
Cell Screening
Protein Analysis
Microfluidic Single Cell Analysis
Bispecifics
Cell Recovery
Antibody Discovery
Antibody Therapies
Therapeutics
Monoclonal Antibody Discovery
T cell engagers
Single Cell Genomics
Cell Culture
Medical

Date founded

2012

Investments made

I

Invetx raised $10M on September 30, 2020

Investors: Anterra Capital, Casdin Capital, LLC, WuXi Biologics and AbCellera

I

Invetx raised $15M on February 24, 2020

Investors: Anterra Capital, WuXi Biologics and AbCellera

FAQ